Metraipolis › archive › dc_5ce403a2ba0b

Reporting of immune-related adverse events in US Food and Drug Administration approvals of immune checkpoint inhibitors — Europe PMC PMID:40881866

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40881866
DOI
10.3389/fonc.2025.1606599
License (as archived)
solo-consultazione
Archived
2026-11-10T16:40:53.122Z
SHA-256 of the archived text
a10634ee1753ddcd7d76a09fafd9407114fe53f7006e85070c540c912391a140
Stable URL of this page
https://metraipolis.com/documento/dc_5ce403a2ba0b

How to cite

Reporting of immune-related adverse events in US Food and Drug Administration approvals of immune checkpoint inhibitors — Europe PMC PMID:40881866 — Europe PMC (en), https://europepmc.org/article/MED/40881866 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_5ce403a2ba0b (Metraipolis archive dc_5ce403a2ba0b, sha256 a10634ee1753ddcd7d76a09fafd9407114fe53f7006e85070c540c912391a140)
BibTeX
@misc{dc5ce403a2ba0b,
  title = {Reporting of immune-related adverse events in US Food and Drug Administration approvals of immune checkpoint inhibitors — Europe PMC PMID:40881866},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40881866},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_5ce403a2ba0b; sha256 a10634ee1753ddcd7d76a09fafd9407114fe53f7006e85070c540c912391a140},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40881866. Agents can read the archived copy with the MCP tool read_document.